BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Solvay Pharmaceuticals, Inc. Release: New Initiative Urges Women to Address Men’s Health This New Year

  January 5, 2009

   · 

  2 min read
• Drug Development

  DOR BioPharma, Inc. Receives SPA Clearance From the FDA to Begin Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

  January 5, 2009

   · 

  9 min read
• Pharm Country

  CAS Medical Systems, Inc. Renews Line of Credit Agreement

  January 5, 2009

   · 

  1 min read
• Business

  Asterand plc Board Appointment

  January 5, 2009

   · 

  1 min read
• Drug Development

  Discovery Laboratories’ Surfaxin(r) Phase 2 BPD Clinical Trial Results Published in Pediatrics

  January 5, 2009

   · 

  1 min read
• Biotech Beach

  Aperio Technologies, Inc. to Present at the JP Morgan 27th Annual Healthcare Conference

  January 5, 2009

   · 

  1 min read
• Deals

  Avexa Limited and Progen Pharmaceuticals Limited Merger Update

  January 5, 2009

   · 

  1 min read
• Genetown

  Concert Pharmaceuticals, Inc. to Present at the 27th Annual J.P. Morgan Healthcare Conference on Monday, January 12

  January 5, 2009

   · 

  1 min read
• Drug Development

  Genmab A/S Announces Interim Results in Pivotal Study of Zalutumumab in Head and Neck Cancer; Phase III Did Not Fulfill a Criterion; Independent Data Monitoring Committee Has Recommended That the Trial Should Continue to Enroll Patients

  January 5, 2009

   · 

  1 min read
• Drug Development

  Genta Incorporated Summarizes Phase 2 Activity and Receives Orphan Drug Designation in Gastric Cancer for Tesetaxel, a Leading Oral Taxane in Clinical Development

  January 5, 2009

   · 

  6 min read